Furthermore, in cats with certain molecular subtypes of FMC (HER2+ and triple negative normal-like), serum levels of VEGFR-1, VEGFR-2 and VEGF-A were significantly elevated, implicating that these molecules may serve as non-invasive biomarkers for these specific tumor types [104]. Here, ERBB2 is linked to neoplasm.